The Impact of Gleason Grade 3 as a Predictive Factor for Biochemical Recurrence after Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group)
Authors:
- Makoto KawaseMKMakoto Kawase
- Shin EbaraSEShin Ebara
- Tomoyuki TatenumaTTTomoyuki Tatenuma
- Takeshi SasakiTSTakeshi Sasaki
- Yoshinori IkehataYIYoshinori Ikehata
- Akinori NakayamaANAkinori Nakayama
- Masahiro ToideMTMasahiro Toide
- Tatsuaki YonedaTYTatsuaki Yoneda
- Kazushige SakaguchiKSKazushige Sakaguchi
- Jun TeishimaJTJun Teishima
- Kazuhide MakiyamaKMKazuhide Makiyama
- Takahiro InoueTakahiro Inoue
Open Access
Abstract
Background and Objectives: This study’s objective was to examine patients treated with robot-assisted radical prostatectomy (RARP) for intermediate-risk prostate cancer (IR-PCa), and to identify preoperative risk factors for biochemical recurrence (BCR) in these patients in Japan. Materials and Methods: We conducted a retrospective multicenter cohort study of patients with PCa who underwent RARP at 10 institutions in Japan. A total of 3195 patients were enrolled in this study. We focused on patients with IR-PCa who underwent RARP. We obtained data on pre- and postoperative covariates from the enrolled patients. Biochemical recurrence-free survival was the primary endpoint of this study. We also identified useful preoperative predictive factors for BCR in patients with IR-PCa after RARP. Results: A total of 1144 patients with IR-PCa were enrolled in this study. The median follow-up period was 23.7 months. At the end of the follow-up period, 94 (8.2%) patients developed BCR. The 2 and 3 year biochemical recurrence-free survival (BRFS) rates were 92.2% and 90.2%, respectively. Using the Kaplan–Meier method, Gleason grade (GG) 3 was significantly associated with poor BRFS compared with ≤GG 2. In multivariate analysis, GG 3 was a significant predictive factor for BCR in patients with IR-PCa. Conclusions: The results of the study indicated a significant relationship between GG 3 and post-RARP BCR in patients with IR-PCa.Keywords
This publication has 26 references indexed in Scilit:
- Stratification of patients with intermediate‐risk prostate cancerBJU International, 2015
- The likelihood of death from prostate cancer in men with favorable or unfavorable intermediate‐risk diseaseCancer, 2014
- A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation TherapyEuropean Urology, 2013
- Value of Prostate Specific Antigen Density and Percent Free Prostate Specific Antigen for Prostate Cancer PrognosisJournal of Urology, 2012
- Contemporary Evaluation of the National Comprehensive Cancer Network Prostate Cancer Risk Classification SystemUrology, 2012
- Biochemical Recurrence After Robot-assisted Radical Prostatectomy in a European Single-centre Cohort with a Minimum Follow-up Time of 5 YearsEuropean Urology, 2012
- Biochemical Recurrence Following Robot-Assisted Radical Prostatectomy: Analysis of 1384 Patients with a Median 5-year Follow-upEuropean Urology, 2010
- Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumorsWorld Journal of Urology, 2010
- Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?Journal of Clinical Oncology, 2009
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998